Eric Simpson
Director, Clinical Research · Oregon Health & Science University
Credentials: · · ·
History
- Present
Clinical Research · Oregon Health & Science University
- 1998–1999
Preliminary or Transitional Year
Research
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
New England Journal of Medicine · 2016 · First of 26 authors · 1,611 citations
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis
New England Journal of Medicine · 2014 · 1,125 citations
The Lancet · 2017 · 980 citations
116 papers · 5 as a resident
67 papers
62 papers
61 papers
- AB
54 papers
- JH
43 papers
- MB
39 papers
26 papers
Grants
- 2024–2027
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $705.5K · Oregon Health & Science University
- 2018–2025
A Community-Based Assessment of Skin Care, Allergies, and Eczema: The CASCADE Trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $4.5M · Oregon Health & Science University
- 2014–2017
Planning a Community-Based Trial of Emollients for Atopic Dermatitis Prevention
National Institute of Arthritis and Musculoskeletal and Skin Diseases · U34
Contact PI · $677.6K · Oregon Health & Science University
- 2010–2015
The Role of the Skin Barrier in Atopic Dermatitis Development and Prevention
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K23
Contact PI · $512.9K · Oregon Health & Science University
Clinical trials
- 2018–2024
A Community-based Assessment of Skin Care, Allergies, and Eczema
Principal investigator · Completed
Oregon Health and Science University
- 2017–2019
Principal investigator · Completed · Phase 3
LEO Pharma
- 2015–2016
Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
Principal investigator · Completed · Phase 2
MedImmune LLC
- 2011–2015
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
Principal investigator · Completed
Oregon Health and Science University